287 related articles for article (PubMed ID: 15241357)
21. Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis.
Kim HO; Lee CH; Ahn HK; Park CW
Int J Dermatol; 2009 Apr; 48(4):431-8. PubMed ID: 19335435
[TBL] [Abstract][Full Text] [Related]
22. [Langerhans cells in the physiopathology of atopic dermatitis].
Bieber T; Bruijnzeel-Koomen C
Ann Dermatol Venereol; 1990; 117(3):185-93. PubMed ID: 2193589
[TBL] [Abstract][Full Text] [Related]
23. Quality of life in patients with atopic dermatitis: impact of tacrolimus ointment.
Kawashima M;
Int J Dermatol; 2006 Jun; 45(6):731-6. PubMed ID: 16796638
[TBL] [Abstract][Full Text] [Related]
24. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
25. Epidermal caspase-3 cleavage associated with interferon-gamma-expressing lymphocytes in acute atopic dermatitis lesions.
Simon D; Lindberg RL; Kozlowski E; Braathen LR; Simon HU
Exp Dermatol; 2006 Jun; 15(6):441-6. PubMed ID: 16689860
[TBL] [Abstract][Full Text] [Related]
26. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
Wollenberg A; Reitamo S; Girolomoni G; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
Allergy; 2008 Jul; 63(7):742-50. PubMed ID: 18592619
[TBL] [Abstract][Full Text] [Related]
27. Tacrolimus ointment (Protopic) for atopic dermatitis.
Pascual JC; Fleisher AB
Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
[TBL] [Abstract][Full Text] [Related]
28. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis.
Patel RR; Vander Straten MR; Korman NJ
Arch Dermatol; 2003 Sep; 139(9):1184-6. PubMed ID: 12975161
[TBL] [Abstract][Full Text] [Related]
29. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
[TBL] [Abstract][Full Text] [Related]
30. Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis.
Bäumer W; Sülzle B; Weigt H; De Vries VC; Hecht M; Tschernig T; Kietzmann M
Br J Dermatol; 2005 Jul; 153(1):136-44. PubMed ID: 16029339
[TBL] [Abstract][Full Text] [Related]
31. The mode of topical immunomodulators in the immunological network of atopic dermatitis.
Novak N; Kwiek B; Bieber T
Clin Exp Dermatol; 2005 Mar; 30(2):160-4. PubMed ID: 15725246
[TBL] [Abstract][Full Text] [Related]
32. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
33. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.
Naylor M; Elmets C; Jaracz E; Rico JM
J Dermatolog Treat; 2005 Aug; 16(3):149-53. PubMed ID: 16096180
[TBL] [Abstract][Full Text] [Related]
34. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
Wollenberg A; Reitamo S; Atzori F; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
Allergy; 2008 Jun; 63(6):742-50. PubMed ID: 18445188
[TBL] [Abstract][Full Text] [Related]
35. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis.
Trautmann A; Akdis M; Schmid-Grendelmeier P; Disch R; Bröcker EB; Blaser K; Akdis CA
J Allergy Clin Immunol; 2001 Nov; 108(5):839-46. PubMed ID: 11692113
[TBL] [Abstract][Full Text] [Related]
36. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.
Dähnhardt-Pfeiffer S; Dähnhardt D; Buchner M; Walter K; Proksch E; Fölster-Holst R
J Dtsch Dermatol Ges; 2013 May; 11(5):437-43. PubMed ID: 23551950
[TBL] [Abstract][Full Text] [Related]
37. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
Abramovits W; Fleischer AB; Jaracz E; Breneman D
J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
[TBL] [Abstract][Full Text] [Related]
38. Modulation of the atopy patch test: tacrolimus 0.1% compared with triamcinolone acetonide 0.1%.
Oldhoff JM; Knol EF; Laaper-Ertmann M; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Allergy; 2006 May; 61(5):622-8. PubMed ID: 16629794
[TBL] [Abstract][Full Text] [Related]
39. The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis.
Novak N; Bieber T
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S171-6. PubMed ID: 16021172
[TBL] [Abstract][Full Text] [Related]
40. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis.
Furukawa H; Nakamura K; Zheng X; Tojo M; Oyama N; Akiba H; Nishibu A; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
J Dermatol Sci; 2004 Jun; 35(1):35-42. PubMed ID: 15194145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
